Testing Experimental Medication in Healthy Subjects
common.study.values.description
“A Single and Multiple Ascending Dose Study in Healthy Subjects to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of KP-1199”
This is a Phase I, randomized, placebo and active-controlled, double blind, single and multiple ascending dose study in healthy adults to evaluate the safety, tolerability, pharmacokinetics and preliminary efficacy of KP-1199
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-yes
common.study.methods.is-healthy-no
Drug - KP-1199
Single dose and Multiple ascending doses of KP-1199 oral capsules
Drug - Placebo oral capsule
Single dose and Multiple dose identical to active treatment but without KP-1199.
Drug - Oxycodone oral capsule
10 mg Oxycodone Capsules
participant.views.study.view.additional
participant.views.study.view.scientific-title
A Randomized, Placebo- and Active-Controlled, Double-Blind, Single and Multiple Ascending Dose Study in Healthy Adults to Determine the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of KP-1199
common.study.values.clinical-trial-id
NCT03880487
participant.views.study.view.id
b4xwkb
